In conjunction with MWC Barcelona 2022 which will be taking place from the 28th of February to the 3rd of March, Tara Neal, Executive Editor of The Fast Mode spoke to Eliott Jones, CEO and Co-founder of Biospectal on the company's plans and showcases for this year's event.
Tara: What do you think MWC 2022 will be all about? And what are your MWC 2022 plans?
Eliott: MWC 2022 Will be about re-connecting, but also expanding the capability of connecting in highly sophisticated ways using remote communication to forge deeper and more productive relationships through new technologies. The past two years have led us to the essential need to remain connected from a distance, and the technology that has developed to support this and social patterns surrounding it will enable more productive, more resilient connection – whether in distributed work modalities, remote patient monitoring in medicine, or virtual social events.
Tara: How has the pandemic impacted the operational and business landscape of the tech segment you are operating in?
Eliott: In our world of medical diagnostics, the pandemic has accelerated and amplified a fundamental transformation in the context of medical care delivery that was already in motion but not yet pervasive. Already remote technologies were enabling the distribution of medical care away from the monolithic setting of hospital and clinic to the patient. What was a coming trend in enabling mobile health connectivity and diagnostic functionality to connect patients, their data, and doctors became essential in the epidemic, with actual benefits of saving time, providing more timely interaction, and moving cost away from the expensive clinical environment. Only via today’s powerful mobile technologies and new highly evolved network and edge sensing in mobile devices is this now possible. This is definitely an inflection point in the relationship between patient and doctor where the patient becomes an active participant in their own care.
Tara: What emerging trends/technologies have you observed in your tech segment in recent months?
Eliott: We are seeing more and more maturation in capturing, making meaning of, and integrating patient data into the core workflows of the clinical care regimen via remote patient monitoring. Not long ago, remote patient monitoring was a vision but today it is rapidly becoming standard operating procedure. In a way, this transformation is only made possible through the distribution via seamless connectivity of clinical grade monitoring to the “point of patient.” Wearables, phones, and other IoT devices all interconnect through digital health hubs and platforms that are now mature in receiving, processing, and securely brokering this data across the participants in care. Anytime, anywhere in the world, in fact. Location has in many ways become irrelevant in the presence of ubiquitous cloud connected devices.
Eliott Jones is CEO and co-founder of Biospectal, the optical biosensing company focused on democratizing hypertension monitoring and management using mobile and IoT device end points. He is a Silicon Valley-based startup veteran with a deep history of leading innovation in digital transformation, emerging connected technologies and product user experience.
